Navigating Multiple Myeloma: From Newly Diagnosed to R/R

Rafael Fonseca, MD​; Binod Dhakal, MD; Doris K. Hansen, MD; and Adriana Rossi, MD, explore evidence-based treatment strategies for newly diagnosed patients, focusing on transplant-ineligible cases, current therapeutic guidelines, and emerging clinical trial data such as the CEPHEUS study comparing daratumumab plus VRd vs VRd alone.